Gijs van Well (G.T.J.)

Vorsteveld, E. E., Van der Made, C. I., Smeekens, S. P., Schuurs-Hoeijmakers, J. H., Astuti, G., Diepstra, H., Gilissen, C., Hoenselaar, E., Janssen, A., van Roozendaal, K., Engelen, J. S., Steyaert, W., Weiss, M. M., Yntema, H. G., Mantere, T., AlZahrani, M. S., van Aerde, K., Derfalvi, B., Faqeih, E. A., ... Members of the Radboud University Medical Center multidisciplinary immune-disease board, Radboud University Medical Center multidisciplinary immune-disease board (2024). Clinical exome sequencing data from patients with inborn errors of immunity: Cohort level diagnostic yield and the benefit of systematic reanalysis. Clinical Immunology, 268, Article 110375. https://doi.org/10.1016/j.clim.2024.110375

de Groot, A., Eijsvoogel, N., van Well, G., van Hout, R., & de Vries, E. (2024). Evidence-based decision-making in the treatment of speech, language, and communication disorders in Down syndrome; a scoping review. Journal of Intellectual Disabilities. Advance online publication. https://doi.org/10.1177/17446295241283659

Verschoof, M. A., van Meenen, L. C. C., Andriessen, M. V. E., Brinkman, D. M. C., Kamphuis, S., Kuijpers, T. W., Leavis, H. L., Legger, G. E., Mulders-Manders, C. M., de Pagter, A. P. J., Rutgers, A., van Well, G. T. J., Coutinho, J. M., Hak, A. E., van Montfrans, J. M., & Klouwer, F. C. C. (2024). Neurological phenotype of adenosine deaminase 2 deficient patients: a cohort study. European Journal of Neurology, 31(1), Article e16043. https://doi.org/10.1111/ene.16043

Andriessen, M. V. E., Legger, G. E., Bredius, R. G. M., van Gijn, M. E., Hak, A. E., Muller, P. C. E. H., Kamphuis, S., Klouwer, F. C. C., Kuijpers, T. W., Leavis, H. L., Nierkens, S., Rutgers, A., van der Veken, L. T., van Well, G. T. J., Mulders-Manders, C. M., & van Montfrans, J. M. (2023). Clinical Symptoms, Laboratory Parameters and Long-Term Follow-up in a National DADA2 Cohort. Journal of Clinical Immunology, 43(7), 1581-1596. https://doi.org/10.1007/s10875-023-01521-8

Bijker, E. M., & van Well, G. T. J. (2023). Immunological Evaluation of Children With a First Severe Bacterial Infection: Standard of Care? Journal of Infectious Diseases, 228(1), 1-3. https://doi.org/10.1093/infdis/jiad099

Eijsvoogel, N. B., Verstegen, R. H. J., van Well, G. T. J., van Hout, R. W. N. M., & de Vries, E. (2022). Increased rate of respiratory symptoms in children with Down syndrome: a 2-year web-based parent-reported prospective study. European Journal of Pediatrics, 181(12), 4079-4089. https://doi.org/10.1007/s00431-022-04634-1

Verheijen, A. C., Janssen, E. E. R., van der Putten, M. E., van Horck, M. W. P., van Well, G. T. J., Van Loo, I. H. M., Hutten, M. C., & Van Mechelen, K. (2022). Management of severe neonatal respiratory distress due to vertical transmission of severe acute respiratory syndrome coronavirus 2: a case report. Journal of Medical Case Reports, 16(1), Article 140. https://doi.org/10.1186/s13256-022-03364-0

Damoiseaux, M., Damoiseaux, J., Pico-Knijnenburg, I., van der Burg, M., Bredius, R., & van Well, G. (2022). Lessons learned from the diagnostic work-up of a patient with the bare lymphocyte syndrome type II. Clinical Immunology, 235, Article 108932. https://doi.org/10.1016/j.clim.2022.108932

van Dongen, J. A. P., Rouers, E. D. M., Schuurman, R., Band, C., Watkins, S. M., van Houten, M. A., Bont, L. J., Norbruis, O. F., Hemels, M. A. C., van Well, G. T. J., Vlieger, A. M., van der Sluijs, J., Stas, H. G., Tramper-Stranders, G., Kleinlugtenbeld, E. A., van Kempen, A. A. M. W., Wessels, M., van Rossem, M. C., Dassel, C. A. C. M., ... Bruijning-Verhagen, P. C. J. (2021). Rotavirus Vaccine Safety and Effectiveness in Infants With High-Risk Medical Conditions. Pediatrics, 148(6), Article 2021051901. https://doi.org/10.1542/peds.2021-051901

van Well, G. T. J., Kant, B., van Nistelrooij, A., Sirma Ekmekci, S., Henriet, S. V., Hoppenreijs, E., van Deuren, M., van Montfrans, J., Nierkens, S., Gül, A., & van Gijn, M. E. (2019). Phenotypic variability including Behçet's disease-like manifestations in DADA2 patients due to a homozygous c.973-2A>G splice site mutation. Clinical and Experimental Rheumatology, 37 Suppl 121(6), 142-146.